CYCLIC PEPTIDE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE P85 SH2 DOMAIN BINDING

被引:20
作者
BURKE, TR
NOMIZU, M
OTAKA, A
SMYTH, MS
ROLLER, PP
CASE, RD
WOLF, G
SHOELSON, SE
机构
[1] HARVARD UNIV, SCH MED, JOSLIN DIABET CTR, BOSTON, MA 02215 USA
[2] HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02215 USA
关键词
D O I
10.1006/bbrc.1994.1825
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cyclic hexameric peptides based on the amino acid sequence ''Gly-Xxx-Val-Pro-Met-Leu'', where Xxx Is either phosphotyrosyl (pTyr) residue or a hydrolytically stable pTyr mimetic, were examined for their ability to bind to the C-terminal SH2 domain of the p85 phosphoinositol 3-kinase (PI 3-kinase). The cyclic peptides retained significant binding affinity relative to their linear counterparts. Potency varied depending on Xxx in the order: phosphonomethyl phenylalanine (Pmp, ID50 = 5.2 mu M) < phosphonodifluoromethyl phenylalanine (F(2)Pmp, ID50 = 2.2 mu M) < pTyr (ID50 = 1.0 mu M), With Xxx = Tyr being inactive (ID50 > 500 M). Greatly reduced potency was observed when Xxx was of the unnatural D-configuration. The cyclic peptides represent conformationally constrained ligands which should be useful in the development of p85 SH2 domain-directed inhibitors. (C) 1994 Academic Press, Inc.
引用
收藏
页码:1148 / 1153
页数:6
相关论文
共 28 条
[1]  
BARCHI JJ, BIOPOLYMERS
[2]   STRUCTURE OF AN SH2 DOMAIN OF THE P85-ALPHA SUBUNIT OF PHOSPHATIDYLINOSITOL-3-OH KINASE [J].
BOOKER, GW ;
BREEZE, AL ;
DOWNING, AK ;
PANAYOTOU, G ;
GOUT, I ;
WATERFIELD, MD ;
CAMPBELL, ID .
NATURE, 1992, 358 (6388) :684-687
[3]   NEW INTRACELLULAR TARGETS FOR THERAPEUTIC DRUG DESIGN [J].
BRUGGE, JS .
SCIENCE, 1993, 260 (5110) :918-919
[4]   CELL-SIGNALING TARGETS FOR ANTITUMOR DRUG DEVELOPMENT [J].
BRUNTON, VG ;
WORKMAN, P .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 32 (01) :1-19
[5]  
BURKE T R JR, 1992, Drugs of the Future, V17, P119
[6]   PROTEIN-TYROSINE KINASES - POTENTIAL TARGETS FOR ANTICANCER DRUG DEVELOPMENT [J].
BURKE, TR .
STEM CELLS, 1994, 12 (01) :1-6
[7]   SYNTHESIS OF 4-PHOSPHONO(DIFLUOROMETHYL)-D, L-PHENYLALANINE AND N-BOC AND N-FMOC DERIVATIVES SUITABLY PROTECTED FOR SOLID-PHASE SYNTHESIS OF NONHYDROLYZABLE PHOSPHOTYROSYL PEPTIDE ANALOGS [J].
BURKE, TR ;
SMYTH, MS ;
OTAKA, A ;
ROLLER, PP .
TETRAHEDRON LETTERS, 1993, 34 (26) :4125-4128
[8]   PREPARATION OF FLUORO-4-(PHOSPHONOMETHYL)-D,L-PHENYLALANINE AND HYDROXY-4-(PHOSPHONOMETHYL)-D,L-PHENYLALANINE SUITABLY PROTECTED FOR SOLID-PHASE SYNTHESIS OF PEPTIDES CONTAINING HYDROLYTICALLY STABLE ANALOGS OF O-PHOSPHOTYROSINE [J].
BURKE, TR ;
SMYTH, MS ;
NOMIZU, M ;
OTAKA, A ;
ROLLER, PP .
JOURNAL OF ORGANIC CHEMISTRY, 1993, 58 (06) :1336-1340
[9]  
BURKE TR, IN PRESS BIOCHEM
[10]   ONCOGENES AND SIGNAL TRANSDUCTION [J].
CANTLEY, LC ;
AUGER, KR ;
CARPENTER, C ;
DUCKWORTH, B ;
GRAZIANI, A ;
KAPELLER, R ;
SOLTOFF, S .
CELL, 1991, 64 (02) :281-302